1. An electromechanical self-boosting disk brake, comprising
an electromechanical actuating device (44), with which a friction brake lining (28, 30) can be pressed for braking against a brake disk (20),
a mechanical self boosting device, which converts a frictional force, exerted in braking by the rotating brake disk on the friction brake lining pressed against it, into a contact pressure that presses the friction brake lining against the brake disk,
a frame caliper (12), the frame caliper (12) having two brake lining holders (14, 16), between which the brake disk (20) is located, and two tie rods (18), which connect the two brake lining holders (14, 16) outside the brake disk (20),
friction brake linings (28, 30) disposed on sides of the brake lining holders (14, 16) oriented toward the brake disk (20); and
means for mounting one of the brake lining holders displaceably along the tie rods (18), so that a spacing of the brake lining holders (14, 16) from one another can be varied, wherein the frame caliper (12) is displaceable transversely to the brake disk (20), and wherein the frame caliper (12) comprises a slide bearing (32, 34), with which it is guided displaceably transversely to the brake disk (20); and wherein the slide bearing (32, 34) is disposed approximately in the same imaginary plane as the brake disk (20).
2. The disk brake in accordance with claim 1, wherein the disk brake (10) has anchor bolts (18) as tie rods, onto which nuts (26) are screwed that hold said one of the brake lining holders, so that by rotation of the nuts (26), the said one of the brake lining holders can be displaced along the anchor bolts (18) and the spacing of the two brake lining holders (14, 16) from one another can be varied.
3. The disk brake in accordance with claim 2, wherein the disk brake (10) further comprising a synchronous drive (58) for the nuts (26).
4. The disk brake in accordance with claim 1, wherein the disk brake (10) further comprising an electromechanical wear readjustment device (60) for displacing the said one of the brake lining holders.
5. The disk brake in accordance with claim 1, wherein the disk brake (10) further comprises a mechanical wear readjustment device (60) for displacing the said one of the brake lining holders, which device is driven by a motion of one friction brake lining (30) in the direction of rotation of the brake disk (20) and displaces the said one of the brake lining holders in the direction of the other brake lining holder (14).
6. The disk brake in accordance with claim 5, wherein the wear readjustment device (60) comprises a torsion element (62), which upon a motion of the said one of the brake lining holders in the direction of rotation of the brake disk (20) is tensed by the friction brake lining (30) and which upon release of the disk brake (10) urges the said one of the brake lining holders in the direction of one brake lining holder (14). and a return block (64) which allows only a limited restoration of the torsion element (62).
7. The disk brake in accordance with claim 6, wherein the torsion element (62) comprises a torsion shaft.
8. The disk brake in accordance with claim 1, wherein the disk brake (10) is embodied as a partial-lining disk brake.
9. The disk brake in accordance with claim 1, wherein the frame caliper (12) is displaceable transversely to the brake disk (20).
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A drug andor food supplement with antiviral effects comprising NISYLEN\xae andor Cepa andor Euphrasia andor Belladonna andor Mercurius solubilis.
2. The drug andor food supplement as claimed in claim 1, wherein the drug or food supplement performs the preventive andor therapeutic treatment of herpes labialis andor herpes genitalis, andor with antibacterial andor immunomodulating andor antiphlogistic effects andor performs preventive andor therapeutic treatment of affections of the prostate.
3. The drug andor food supplement as claimed in claim 2, wherein it includes NISYLEN\xae as a main ingredient and one or more of the further ingredients as secondary ingredients.
4. The drug andor food supplement as claimed in claim 2, wherein the drug includes Cepa as a main ingredient and one or more of the further ingredients as secondary ingredients.
5. The drug andor food supplement as claimed in claim 2, wherein it contains Euphrasia as a main ingredient and one or more of the further ingredients as secondary ingredients.
6. The drug andor food supplement as claimed in claim 2, wherein it contains Belladonna as a main ingredient and one or more of the further ingredients as secondary ingredients.
7. The drug andor food supplement as claimed in claim 2, wherein it contains Mercurius solubilis as a main ingredient and one or more of the further ingredients as secondary ingredients.
8. The drug andor food supplement as claimed in claim 2, further comprising instructions identifying use for treatment of the prostate is a prostatitis or degenerations of the prostate.
9. The drug andor food supplement as claimed in claim 2, wherein the ingredients Cepa, Euphrasia and Mercurius solubilis are present in the dilution D12 and Belladonna in the dilution D15.
10. The drug andor food supplement as claimed in claim 2, wherein it includes NISYLEN\xae, Cepa, Euphrasia, Belladonna and Mercurius solubilis.
11. The drug andor food supplement as claimed in claim 10, wherein the ingredient NISYLEN\xae is present in two to four times the amount of any of the other ingredients.
12. The drug andor food supplement as claimed in claim 10, wherein it includes NISYLEN\xae in a weight or in a volume of 4.0 to 4.5 g or ml, and Cepa, Euphrasia, Belladonna and Mercurius solubilis each in a weight or in a volume of 1.2 to 1.6 g or ml per 10 ml of solution.
13. The drug andor food supplement as claimed in claim 10, wherein it is present in liquid form.
14. The drug andor food supplement as claimed in claim 13, wherein it is an alcoholic solution.
15. The drug andor food supplement as claimed in claim 2, wherein it is present in solid or pasty form.
16. The drug andor food supplement as claimed in claim 2, wherein the ingredient NISYLEN\xae includes the following ingredients: Aconitum napellus, Gelsemium sempervirens, Cephaelis ipecacuanha, Phosphorus, Bryonia and Eupatorium perfoliatum.
17. The drug andor food supplement as claimed in claim 16, wherein per 1 g of NISYLEN\xae the ingredients are included in the following amounts: 100 mg of Aconitum napellus D3, 100 mg of Gelsemium sempervirens D3, 100 mg Cephaelis ipecacuanha D3, 100 mg of Phosphorus D5, 100 mg of Bryonia D2 and 100 mg of Eupatorium perfoliatum D1.
18. A method, comprising:
manufacturing a drug andor food supplement with antiviral effects, said manufacturing including using NISYLEN\xae andor Cepa andor Euphrasia andor Belladonna andor Mercurius solubilis.
19. The method of claim 18, wherein said drug andor food supplement preventively andor therapeutically treats herpes labialis andor herpes genitalis, andor said drug andor food supplement includes antibacterial andor immunomodulating andor antiphlogistic effects, andor preventively andor therapeutically treats affections of the prostate
20. A method, comprising
preventing andor therapeutically treating herpes labialis andor herpes genitalis by using NISYLEN\xae andor Cepa andor Euphrasia andor Belladonna andor Mercurius solubilis as a drug andor food supplement with antiviral effects.
21. A method, comprising
preventing andor therapeutically treating affections of the prostate by using NISYLEN\xae andor Cepa andor Euphrasia andor Belladonna andor Mercurius solubilis as a drug andor food supplement andor with antibacterial andor immunomodulating andor antiphlogistic effects.
22. A method, comprising
preventing andor therapeutically treating a virus in a human by using a drug andor food supplement having antiviral effects, the drug andor food supplement comprising NISYLEN\xae andor Cepa andor Euphrasia andor Belladonna andor Mercurius solubilis.
23. The drug andor food supplement as claimed in claim 10, where NISYLEN\xae is present in a larger amount than Cepa, Euphrasia, Belladonna and Mercurius solubilis.